{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:59:14Z","timestamp":1793775554143,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ajic.2017.07.029","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T15:46:00Z","timestamp":1505835960000},"page":"e1-e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Sui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2017.07.029_bib0010","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","article-title":"The effectiveness of varicella vaccination in children in Germany: a case-control study","volume":"32","author":"Liese","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7748\/ns2014.04.28.33.52.e8249","article-title":"Varicella zoster virus: chickenpox and shingles","volume":"28","author":"Gould","year":"2014","journal-title":"Nurs Stand"},{"key":"10.1016\/j.ajic.2017.07.029_bib0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1542\/peds.75.4.667","article-title":"Long-term protective immunity of recipients of the OKA strain of live varicella vaccine","volume":"75","author":"Asano","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajic.2017.07.029_bib0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00006454-199510000-00011","article-title":"Over five-year follow-up of Oka\/Merck varicella vaccine recipients in 465 infants and adolescents","volume":"14","author":"Clements","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0030","first-page":"382","article-title":"Three-year follow-up of protection rates in children given varicella vaccine","volume":"13","author":"Scheifele","year":"2002","journal-title":"Can J Infect Dis"},{"key":"10.1016\/j.ajic.2017.07.029_bib0035","doi-asserted-by":"crossref","first-page":"e20153741","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"issue":"Suppl","key":"10.1016\/j.ajic.2017.07.029_bib0040","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2013United States, 1995-2005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2017.07.029_bib0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajic.2017.07.029_bib0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jpids\/piv044","article-title":"Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994-2012","volume":"5","author":"Leung","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.ajic.2017.07.029_bib0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.36153","article-title":"Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012","volume":"11","author":"Tafuri","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ajic.2017.07.029_bib0060","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/CVI.00645-13","article-title":"Varicella and varicella vaccination in South Korea","volume":"21","author":"Oh","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ajic.2017.07.029_bib0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12879-016-1898-z","article-title":"Increasing incidence associated with herpes zoster infection in British Columbia, Canada","volume":"16","author":"Marra","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2017.07.029_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2015.06.003","article-title":"Outbreak of varicella in a highly vaccinated preschool population","volume":"37","author":"Fu","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajic.2017.07.029_bib0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.22373","article-title":"Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV","volume":"9","author":"Tafuri","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ajic.2017.07.029_bib0080","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajic.2017.07.029_bib0085","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1080\/21645515.2016.1190056","article-title":"Seropositivity of varicella zoster virus in vaccinated Korean children and MAV vaccine group","volume":"12","author":"Choi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ajic.2017.07.029_bib0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00006454-200204000-00014","article-title":"Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection","volume":"21","author":"Li","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl","key":"10.1016\/j.ajic.2017.07.029_bib0095","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1086\/522124","article-title":"Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program","volume":"197","author":"Black","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2017.07.029_bib0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","article-title":"Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"171","author":"Knuf","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajic.2017.07.029_bib0105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2017.07.029_bib0110","first-page":"611","article-title":"Varicella breakthrough infection and vaccine effectiveness with 1-dose varicella","volume":"49","author":"Pan","year":"2015","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.ajic.2017.07.029_bib0115","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajic.2017.07.029_bib0120","author":"Wells"},{"key":"10.1016\/j.ajic.2017.07.029_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Software"},{"key":"10.1016\/j.ajic.2017.07.029_bib0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.ajic.2017.07.029_bib0135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00006454-199912000-00003","article-title":"Postmarketing evaluation of the safety and effectiveness of varicella vaccine","volume":"18","author":"Black","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.11150\/kansenshogakuzasshi1970.64.188","article-title":"Mild varicella observed in children vaccinated with varicella vaccine between 1984 and 1987","volume":"64","author":"Takayama","year":"1990","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.ajic.2017.07.029_bib0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0264-410X(91)90189-D","article-title":"Oka\/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies","volume":"9","author":"Kuter","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.ajic.2017.07.029_bib0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006454-199201000-00006","article-title":"Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response","volume":"11","author":"White","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1542\/peds.91.1.17","article-title":"Modified chickenpox in children immunized with the Oka\/Merck varicella vaccine","volume":"91","author":"Watson","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajic.2017.07.029_bib0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1542\/peds.100.5.761","article-title":"A long-term prospective study of varicella vaccine in healthy children","volume":"100","author":"Johnson","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajic.2017.07.029_bib0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1442-200X.1997.tb03664.x","article-title":"High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain)","volume":"39","author":"Takayama","year":"1997","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.ajic.2017.07.029_bib0170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/adc.79.6.478","article-title":"Risk factors for breakthrough varicella in healthy children","volume":"79","author":"Lim","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ajic.2017.07.029_bib0175","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00006454-199811000-00003","article-title":"Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX","volume":"17","author":"Shinefield","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0180","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00006454-199912000-00004","article-title":"Postlicensure study of varicella vaccine effectiveness in a day-care setting","volume":"18","author":"Clements","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mic.2003.58","article-title":"Varicella vaccine safety, incidence of breakthrough, and factors associated with breakthrough in Taiwan","volume":"31","author":"Tseng","year":"2003","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajic.2017.07.029_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.inf.0000114906.78716.64","article-title":"Use of a computerized database to study the effectiveness of an attenuated varicella vaccine","volume":"23","author":"Passwell","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajic.2017.07.029_bib0205","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.vaccine.2011.01.092","article-title":"Varicella breakthrough infection and vaccine effectiveness in Taiwan","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ajic.2017.07.029_bib0210","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/j.ijid.2011.03.016","article-title":"Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey","volume":"15","author":"Kurugol","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajic.2017.07.029_bib0215","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2011.02.067","article-title":"Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses","volume":"29","author":"Rumke","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ajic.2017.07.029_bib0220","first-page":"1114","article-title":"Evaluation of immune effect of Tianjin Binhai New Area of varicella vaccine","author":"Dong","year":"2014","journal-title":"Chin J Immunol"},{"key":"10.1016\/j.ajic.2017.07.029_bib0225","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.vaccine.2014.04.069","article-title":"The epidemiology of varicella cases among children in Beijing's Fengtai District from 2008 to 2012","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ajic.2017.07.029_bib0230","first-page":"119","article-title":"Assessment of the effectiveness of the universal varicella vaccination program in Toscana (Italy), in the period 2010-2013","volume":"39","author":"Pieri","year":"2015","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.ajic.2017.07.029_bib0235","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1097\/MD.0000000000001721","article-title":"Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety","volume":"94","author":"Ma","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajic.2017.07.029_bib0240","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinids\/20.2.316","article-title":"Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine","volume":"20","author":"Watson","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.ajic.2017.07.029_bib0245","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","article-title":"Efficacy of high-titer live attenuated varicella vaccine in healthy young children","volume":"174","author":"Varis","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2017.07.029_bib0250","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/340868","article-title":"An Outbreak of varicella among children attending preschool and elementary school in Illinois","volume":"35","author":"Dworkin","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655317309458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655317309458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:48:57Z","timestamp":1759297737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655317309458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0196655317309458"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2017.07.029","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2017.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.","name":"copyright","label":"Copyright"}]}}